Open AccessImmunogenicity and safety of a severe acute respiratory syndrome coronavirus 2 inactivated vaccine in healthy adults: randomized, double-blind, and placebo-controlled phase 1 and phase 2 clinical trials
Author(s) -
Hongxing Pan,
Jiankai Liu,
Baoying Huang,
Gui-Fan Li,
Xianyun Chang,
Yafei Liu,
Wenling Wang,
Kai Cui,
Jialei Hu,
Jingxin Li,
Dandan Zhu,
Jingliang Wu,
Xiaoyu Xu,
Li Zhang,
Meng Wang,
Wenjie Tan,
Weijin Huang,
Fengcai Zhu
Publication year - 2021
Publication title -
chinese medical journal/chinese medical journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.537
H-Index - 63
eISSN - 2542-5641
pISSN - 0366-6999
DOI - 10.1097/cm9.0000000000001573
Subject(s) - medicine , placebo , seroconversion , clinical endpoint , immunogenicity , regimen , randomized controlled trial , adverse effect , clinical trial , immunology , antibody , pathology , alternative medicine